Hurley Ariel's Form 4 filing
Blueprint Medicines Corp (BPMC) · filed May 6, 2024
- Accession no.
- 0001415889-24-012356
- Filed
- May 6, 2024
- Trade date
- May 2, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $190.5K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hurley ArielCIK 0001769740 | Officer (PRINCIPAL ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | Common Stock | MOption exerciseAcquired | +1,834 | $54.13 | +$99,274.42 | 16,747 | Direct | |
| May 2, 2024 | Common Stock | SSaleDisposed | −1,834 | $103.88 | −$190,515.92 | 14,913 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 2, 2024 | Common Stock | MOption exerciseDisposed | −1,843 | $0.00 | $0 | 5,503 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.